CIK 0000725363
- Non-accelerated filer
- Smaller reporting company
CEL SCI CORP
Sign in to watch- Ticker
- CVM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- CO
- Entity type
- Operating
- EIN
- 840916344
- Phone
- +1 703-506-9460
- Business address
- 8229 BOONE BLVD ., SUITE 802, VIENNA, VA, 22182
- Open-market buys, last 90 days
- $138,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$138,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-07-24 | KERSTEN GEERT R Chief Executive Officer | Grant or award · Series NN Warrant | +109,170 | $0.01 | $1K | 797,611 |
| 2017-06-30 | ZIMMERMAN DANIEL H Sr. Vice President | Grant or award | +1,532 | $2.23 | $3K | 10,693 |
| 2017-06-30 | TALOR EYAL Chief Scientific Officer | Grant or award | +1,076 | $2.23 | $2K | 133,331 |
| 2017-06-30 | KERSTEN GEERT R Chief Executive Officer | Grant or award | +1,782 | $2.23 | $4K | 482,842 |
| 2017-06-30 | PRICHEP PATRICIA B Sr. Vice President | Grant or award | +1,645 | $2.23 | $4K | 137,483 |
| 2017-06-29 | ZIMMERMAN DANIEL H Senior Vice President | Grant or award · Options | +6,000 | $0.01 | $60 | 28,968 |
| 2017-06-22 | KERSTEN GEERT R Chief Executive Officer | Grant or award · Convertible Note | +147,929 | $250,000.00 | $37.0B | 459,788 |
| 2017-06-22 | KERSTEN GEERT R Chief Executive Officer | Grant or award · Series MM Warrants | +147,929 | $0.01 | $1K | 607,717 |
| 2017-06-12 | BAILLAVOINE BRUNO JEAN-MARIE Director | Grant or award · Options | +7,500 | $0.01 | $75 | 17,500 |
| 2017-06-12 | ESTERHAZY ALEXANDER G Director | Grant or award · Options | +7,500 | $0.01 | $75 | 30,373 |
| 2017-06-12 | YOUNG PETER R Director | Grant or award · Options | +7,500 | $0.01 | $75 | 30,587 |
| 2017-03-31 | ZIMMERMAN DANIEL H Senior Vice President | Grant or award | +39,911 | $0.09 | $3K | 229,023 |
| 2017-03-31 | TALOR EYAL Chief Scientific Officer | Grant or award | +28,037 | $0.09 | $2K | 3,306,368 |
| 2017-03-31 | PRICHEP PATRICIA B Senior Vice President | Grant or award | +42,869 | $0.09 | $4K | 3,395,947 |
| 2017-03-31 | KERSTEN GEERT R Chief Executive Officer | Grant or award | +46,436 | $0.09 | $4K | 12,026,505 |
| 2016-12-30 | ZIMMERMAN DANIEL H Sr. Vice President | Grant or award | +46,026 | $0.07 | $3K | 189,112 |
| 2016-12-30 | TALOR EYAL Chief Scientific Officer | Grant or award | +35,820 | $0.07 | $2K | 3,278,331 |
| 2016-12-30 | PRICHEP PATRICIA B Sr. Vice President | Grant or award | +50,206 | $0.07 | $3K | 3,353,078 |
| 2016-12-30 | KERSTEN GEERT R CEO | Grant or award | +59,328 | $0.07 | $4K | 11,980,069 |
| 2016-09-30 | ZIMMERMAN DANIEL H Senior Vice President | Grant or award | +11,388 | $0.30 | $3K | 143,086 |
Page 16 of 17 · 329 trades